Hsiao-Chun Su

Kaohsiung Medical University

Papers

1

Total Citations

3

H-Index

1

About

Dr. Hsiao-Chun Su is a clinician-researcher whose work centers on improving outcomes for prostate cancer patients, particularly those facing biochemical recurrence after radical prostatectomy. Her most-cited study investigates the critical role of positive surgical margins in driving recurrence, analyzing a cohort of 111 patients to evaluate how adjuvant therapy can mitigate this risk. By clarifying which patients benefit most from early intervention, Dr. Su’s research directly informs surgical decision-making and post-operative management. Though early in her career, her work has already garnered attention, with her top paper cited three times—a strong signal of its relevance in the urologic oncology community. Dr. Su’s contributions bridge the gap between pathology and treatment, offering evidence-based guidance for personalized care. Her focus on translating clinical data into actionable strategies makes her a rising voice in the fight against prostate cancer recurrence, with implications for reducing unnecessary treatments while targeting those most at risk.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Evaluating the effectiveness of adjuvant therapy on biochemical recurrence in prostate cancer patients with positive surgical margins after radical prostatectomy
3 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Kaohsiung Medical University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago